- Sputnik Light gets approval in India for trials
- The vaccine has shown an efficacy rate of 79.4%
The SEC allows Sputnik Light to conduct phase 3 trials in India. This Covid-19 vaccine is single dose vaccine. Dr Reddy's Laboratories and Russian Direct Investment Fund will be to conducting the trials.
The Central Drugs Standard Control Organization gave a sta....
Tags : Sputnik Light, Dr. Reddy’s, Efficacy, Single-Dose,